课题基金 / 基金详情

Enhancement of protection against various microbial infection by the modification of dominance of Thl or Th2 immune responses

Enhancement of protection against various microbial infection by the modification of dominance of Thl or Th2 immune responses
通过改变Th1或Th2免疫反应的优势来增强针对各种微生物感染的保护
批准号:
11470070
负责人:
OKUDA Kenji
金额:
$9.79万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2001

项目摘要

项目成果

OKUDA Kenji的其他基金

相似基金

相关文献

中文摘要
翻译
为探讨新型DNA疫苗对假单胞菌、HIV和流感病毒感染的保护诱导作用,进行了一项实验。疫苗是通过插入编码病原生物各种保护性抗原的基因来构建的。此外,我们还利用人源化的椰子合成了DNA。对于HIV疫苗,按照给药方法进行了有效性、免疫原性和安全性的检查。为了做到这一点,编码HIV-1抗原表位的18个基因被串联起来,每个基因由大约15个氨基酸组成。对给怀孕动物接种DNA疫苗是否会由于胎盘渗透而在后代中诱导更高的免疫原性进行了研究。结果表明,在子代中有较高的免疫原性。此外,不同的DNA疫苗口服、鼻腔、经皮、静脉和直肠给药方式对粘膜免疫、局部免疫和全身免疫均有不同的效果。在流感病毒疫苗的研究中,为了激活CTL反应,我们构建了表达病毒核心蛋白M蛋白的M基因表达载体。这种DNA疫苗被证明对使用各种流感病毒的挑战是有效的。这些结果高度暗示,这些所谓的人源化密码子多价DNA疫苗将对各种微生物有效,并将成为下一代的疫苗。
英文摘要
An experiment was conducted to test the possibility of protection inducement by a new type of DNA vaccine against Pseudomonas, HIV and influenza virus infection. The vaccine was constructed by inserting genes, which code the various protective antigens of the pathogenic organism. In addition, we synthesized DNA by using humanized codons.For the HIV vaccine, an examination was conducted to check the efficacy, immunogenicity and safety according to the method of medication. In order to do this the 18 genes that code HIV-1 antigenic epitopes, each made of about 15 amino acids, were connected in series. Investigations were made as to whether administrating DNA vaccine to pregnant animals will induce a higher immunogenicity in the offspring due to placental penetration. Results suggesting a possibility of higher immunogenicity in the offspring were obtained. Moreover, varying the administration method of the DNA vaccine by i.e. oral, intranasal, percutaneous, intravenous and rectal showed different results in mucosal, local and systemic immunities. In the research of the influenza virus vaccine, with the view to activate the CTL response,we constructed M gene plasmid that expresses the M protein which is the core of the virus. This DNA vaccine was revealed to be effective against the challenge using various influenza viruses. These results are highly suggestive that these so-called "humanized codon multivalent DNA vaccines" will be effective against various microorganisms and will be a vaccine for the next generation.
期刊论文(217)
专著(0)
科研奖励(0)
会议论文
Kusakabe K-i.: "The timing of GM-CSF expression plasmid administration influences the Th1/Th2 response induced by an HIV-1 specific DNA vaccine"J.Immunol.. 164・6. 3102-3111 (2000)
Kusakabe K-i.:“GM-CSF表达质粒施用的时机影响HIV-1特异性DNA疫苗诱导的Th1/Th2反应”J.Immunol.. 164・6(2000)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hagiwara E.: "IL-12-encoding plasmid has a beneficial effect on spontaneous autoimmune disease in MRL/MP-lpr/lpr mice"Cytokine. 18. 1035-1041 (2000)
Hagiwara E.:“IL-12 编码质粒对 MRL/MP-lpr/lpr 小鼠的自发性自身免疫性疾病具有有益作用”细胞因子。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kawamoto S.: "Methods in Molecular Biology "NMDA Receptor Protocols", Expression of NMDA receptor channel subunit proteins using baculovirus and herpesvirus vectors"Humana Press Inc., Totowa, NJ., M.Li(Ed.). 19-32 (1999)
Kawamoto S.:“分子生物学方法“NMDA 受体方案”,使用杆状病毒和疱疹病毒载体表达 NMDA 受体通道亚基蛋白”Humana Press Inc.,Totowa,NJ.,M.Li(编辑)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Okuda K.: "Methods in Molecular Medicine "DNA Vaccines : Methods and Protocols", Cytokine and costimulatory factor-encoding plasmids as adjunvants for DNA vaccination"Humana press, Totowa, NJ., D.B.a.W.Lowrie, R.G.(Ed.). 197-204 (1999)
Okuda K.:“分子医学方法“DNA 疫苗:方法和方案”,细胞因子和共刺激因子编码质粒作为 DNA 疫苗接种的佐剂”Humana press,Totowa,NJ.,D.B.a.W.Lowrie,R.G.(编辑)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 74 条
    Developmental research of new generation DNA vaccine against microorganism using synthesized DNA
    • 批准号:
      15390145
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.86万
    • 财政年份:
      2003
    • 负责人:
      OKUDA Kenji
    • 依托单位:
    Study on the DNA immunization against microbial infection
    • 批准号:
      10044308
    • 项目类别:
      Grant-in-Aid for Scientific Research (C).
    • 资助金额:
      $1.73万
    • 财政年份:
      1998
    • 负责人:
      OKUDA Kenji
    • 依托单位:
    Roles of activation of antigen specific cytoxic T cells against micro bial infections.
    • 批准号:
      09670293
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.73万
    • 财政年份:
      1997
    • 负责人:
      OKUDA Kenji
    • 依托单位:
    国内基金
    海外基金
    Pseudomonas sp. ZM23三氯生分解代谢及其调控机理研究
    • 批准号:
      32370117
    • 项目类别:
      面上项目
    • 资助金额:
      50万元
    • 批准年份:
      2023
    • 负责人:
      吕镇梅
    • 依托单位:
    OSA2 在联合固氮菌 Pseudomonas otitidis H40-2 促进水稻铵态氮吸收中的作用机制研究
    • 批准号:
      --
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2022
    • 负责人:
      董萌
    • 依托单位:
    c-di-GMP合成酶基因digC调控Pseudomonas azotoformans ZY-1风化硅酸盐矿物分子机制研究
    • 批准号:
      --
    • 项目类别:
      --
    • 资助金额:
      58万元
    • 批准年份:
      2022
    • 负责人:
      盛下放
    • 依托单位:
    群体感应LasI-LasR系统在Pseudomonas taiwanensis WRS8减少小麦镉吸收中的作用机制
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      56万元
    • 批准年份:
      2021
    • 负责人:
      程诚
    • 依托单位: